Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

COMPARATIVE EFFECTS OF DRY NEEDLING AND NEURAL MOBILIZATION ON PAIN, STRENGTH AND RANGE OF MOTION IN PATIENTS WITH GOLFER'S ELBOW (DN-NM-GE)

8 de junio de 2026 actualizado por: Abeela Ashraf, Green International University
This randomized clinical trial aims to compare the effectiveness of Dry Needling and Neural Mobilization in patients diagnosed with Golfer's Elbow (Medial Epicondylitis). The study will evaluate the effects of both interventions on pain intensity, grip strength, and range of motion. Participants will be randomly allocated to either the Dry Needling group or the Neural Mobilization group and treated over a specified intervention period. Outcome measures will be assessed at baseline and after treatment to determine which intervention provides greater improvement in pain reduction, muscle strength, and functional mobility. The results may contribute to evidence-based rehabilitation strategies for managing Golfer's Elbow

Descripción general del estudio

Descripción detallada

Golfer's Elbow (Medial Epicondylitis) is a common musculoskeletal disorder characterized by pain and tenderness over the medial epicondyle of the elbow, often associated with repetitive wrist flexion and forearm pronation activities. The condition can lead to decreased grip strength, restricted range of motion, and impaired functional performance, affecting daily activities and quality of life.

Various physiotherapy interventions have been used for the management of Golfer's Elbow, including Dry Needling and Neural Mobilization. Dry Needling is a technique that targets myofascial trigger points to reduce pain, improve blood flow, and restore muscle function. Neural Mobilization aims to restore the normal mobility and physiological function of peripheral nerves by reducing neural tension and improving neural mechanics.

The purpose of this randomized clinical trial is to compare the effectiveness of Dry Needling and Neural Mobilization in reducing pain, improving grip strength, and increasing range of motion in patients with Golfer's Elbow. Eligible participants will be randomly assigned to one of two intervention groups. Baseline assessments will be conducted before treatment, followed by post-intervention assessments after completion of the treatment protocol.

Primary outcome measures will include pain intensity, assessed using a validated pain scale, while secondary outcomes will include grip strength and elbow/wrist range of motion. Data collected will be analyzed to determine whether one intervention demonstrates superior clinical outcomes compared to the other.

The findings of this study are expected to provide evidence regarding the comparative effectiveness of these commonly used physiotherapy interventions and may assist clinicians in selecting appropriate treatment strategies for patients with Golfer's Elbow.

Tipo de estudio

Intervencionista

Inscripción (Actual)

29

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • Punjab Province
      • Lahore, Punjab Province, Pakistán, 54000
        • Green International University

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto

Acepta Voluntarios Saludables

No

Descripción

Inclusion Criteria:

  • • Both male and female patients were included.

    • Diagnosis of Medial Epicondylitis by spiral test clinically confirmed by orthopaedic.

pain is limited on medial epicondyle

  • Pain reproduced with resisted wrist flexion and/or forearm pronation.
  • Aged between 18-40 years
  • Acute to Subacute stage (≥ 6 weeks and ≤ 12 months
  • NPRS score ≥ 4/10 at baseline

Exclusion Criteria:

  • • History of Other elbow pathologies e.g (Lateral epicondylitis , Olecranon bursitis ,Ligament injuries)

    • Radial or ulnar neuropathies not associated with medial epicondylitis.
    • Systemic or inflammatory conditions affecting tendons, such as rheumatoid arthritis
    • Diabetes with neuropathy (unless controlled and neuropathy absent)
    • Previous surgical procedures around the elbow or wrist within the past 6 months
    • Corticosteroid injection, PRP or shockwave therapy within the last 3 months

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Dry needling
Participants will receive dry needling combined with conventional physiotherapy twice weekly for 6 weeks
Participants will receive dry needling to the affected forearm muscles along with conventional physiotherapy. Treatment will be administered twice weekly for 6 weeks, totaling 12 sessions. Outcomes will include pain, grip strength, and range of motion
Participants will receive neural mobilization techniques along with conventional physiotherapy. Treatment will be administered twice weekly for 6 weeks, totaling 12 sessions. Outcomes will include pain, grip strength, and range of motion.
Experimental: Neural mobilization
Participants will receive neural mobilization combined with conventional physiotherapy twice weekly for 6 weeks
Participants will receive dry needling to the affected forearm muscles along with conventional physiotherapy. Treatment will be administered twice weekly for 6 weeks, totaling 12 sessions. Outcomes will include pain, grip strength, and range of motion
Participants will receive neural mobilization techniques along with conventional physiotherapy. Treatment will be administered twice weekly for 6 weeks, totaling 12 sessions. Outcomes will include pain, grip strength, and range of motion.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Pain intensity
Periodo de tiempo: Baseline and at 6 weeks post-intervention
Pain intensity will be assessed using the Numeric Pain Rating Scale (NPRS). The scale ranges from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores represent greater pain intensity.
Baseline and at 6 weeks post-intervention

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Grip strength
Periodo de tiempo: Baseline and at 6 weeks post-intervention
Grip strength will be measured using a hand dynamometer. Higher values indicate greater muscle strength.
Baseline and at 6 weeks post-intervention
Range of motion
Periodo de tiempo: Baseline and at 6 weeks post-intervention
Elbow and wrist range of motion will be measured using a standard goniometer. Higher values indicate improved joint mobility.
Baseline and at 6 weeks post-intervention

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Prof Dr Fahad Tanveer, Green international University lahore

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

1 de enero de 2025

Finalización primaria (Actual)

5 de marzo de 2026

Finalización del estudio (Actual)

10 de mayo de 2026

Fechas de registro del estudio

Enviado por primera vez

8 de junio de 2026

Primero enviado que cumplió con los criterios de control de calidad

8 de junio de 2026

Publicado por primera vez (Actual)

11 de junio de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

11 de junio de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

8 de junio de 2026

Última verificación

1 de junio de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Descripción del plan IPD

Due to patients privacy and confidentiality , IPD will not be shared

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Ensayos clínicos sobre Epicondilitis medial

Ensayos clínicos sobre Dry needling

Suscribir